InvestorsHub Logo
Followers 1
Posts 871
Boards Moderated 0
Alias Born 01/20/2005

Re: None

Wednesday, 02/09/2005 9:24:06 AM

Wednesday, February 09, 2005 9:24:06 AM

Post# of 12383
I challenge anyone here to name any clinical stage compound in the drug development universe that has the incredible potential and safety profile of Panzem NCD. The broad reaching indications from cancer, to inflammation, to Alzheimers's could be monumental. But then again, I'm partial; I'm a significant shareholder. However, I'm "in the industry" and I have the opportunity to see what going on in drug development in a broad range of companies, and I firmly believe that ENMD is highly undervalued and generally undiscovered. In this time of patent expirations and horrible safety issues with the "big boys", ENMD is poised for...Well, I guess we will see.